| Molecular Interaction Atlas (MIA) |
|
| Indication(s) of Maprotiline |
| Disease Entry |
ICD 11 |
Status |
REF |
| Depression |
6A70-6A7Z
|
Approved |
[2] |
| Major depressive disorder |
6A70.3
|
Approved |
[3] |
| Mixed anxiety and depressive disorder |
N.A.
|
Investigative |
[2] |
|
|
|
Maprotiline Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
Norepinephrine transporter (NET)
|
TTAWNKZ
|
SC6A2_HUMAN
|
Inhibitor
|
[5] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Maprotiline Interacts with 2 DME Molecule(s)
| DME Name |
DME ID |
UniProt ID |
Mode of Action |
REF |
|
Cytochrome P450 1A2 (CYP1A2)
|
DEJGDUW
|
CP1A2_HUMAN
|
Metabolism
|
[6] |
|
Cytochrome P450 2D6 (CYP2D6)
|
DECB0K3
|
CP2D6_HUMAN
|
Metabolism
|
[6] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Maprotiline Interacts with 2 DOT Molecule(s)
| DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
|
Cytochrome P450 2D6 (CYP2D6)
|
OTZJC802
|
CP2D6_HUMAN
|
Increases ADR
|
[7] |
|
Beclin-1 (BECN1)
|
OT4X293M
|
BECN1_HUMAN
|
Increases Expression
|
[8] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
| Indication(s) of Pizotyline |
| Disease Entry |
ICD 11 |
Status |
REF |
| Headache |
8A80-8A84
|
Approved |
[4] |
|
|
|
Pizotyline Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
5-HT receptor (5HTR)
|
TT85JO3
|
NOUNIPROTAC
|
Modulator
|
[3] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Pizotyline Interacts with 1 DME Molecule(s)
| DME Name |
DME ID |
UniProt ID |
Mode of Action |
REF |
|
UDP-glucuronosyltransferase 2B10 (UGT2B10)
|
DEI8NGH
|
UDB10_HUMAN
|
Metabolism
|
[9] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Pizotyline Interacts with 1 DOT Molecule(s)
| DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
|
Potassium voltage-gated channel subfamily H member 2 (KCNH2)
|
OTZX881H
|
KCNH2_HUMAN
|
Decreases Activity
|
[10] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
|
|
|
|
|
|